Literature DB >> 25833769

Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.

Lockwood G Taylor1, Rosenie Thelus Jean, Geoff Gordon, David Fram, Trinka Coster.   

Abstract

PURPOSE: The aim of this study was to develop a mother-child linked database consisting of all eligible active duty military personnel, retirees, and their dependents in order to conduct medication-related analyses to improve the safety and quality of care in the Military Health System (MHS).
METHODS: Eligible women of reproductive age with at least one pregnancy-related encounter between January 2005 and December 2013 receiving care in the MHS were included in the study population. Building on previously published algorithms, we used pregnancy-related diagnostic and procedure codes, parameterized temporal constraints, and data elements unique to the MHS to identify pregnancies ending in live births, stillbirth, spontaneous abortion, or ectopic pregnancy. Pregnancies ending in live births were matched to presumptive offspring using birth dates and family-based sponsorship identification. Antidepressant and antiepileptic use during pregnancy was evaluated using electronic pharmacy data.
RESULTS: Algorithms identified 755,232 women who experienced 1,099,648 complete pregnancies with both pregnancy care encounter and pregnancy outcome. Of the 924,320 live birth pregnancies, 827,753 (90.0%) were matched to offspring. Algorithms also identified 5,663 stillbirths, 11,358 ectopic pregnancies, and 169,665 spontaneous abortions. Among the matched singleton live birth pregnancies, 7.1% of mothers were dispensed an antidepressant at any point during pregnancy, usually a selective serotonin reuptake inhibitor, (75.3%), whereas 1.3% of mothers were dispensed an antiepileptic drug.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Department of Defense; adverse drug events; claims databases; military health; pharmacoepidemiology; pregnancies; pregnancy outcomes

Mesh:

Substances:

Year:  2015        PMID: 25833769     DOI: 10.1002/pds.3759

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  6 in total

1.  Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Authors:  Elizabeth C Ailes; Regina M Simeone; April L Dawson; Emily E Petersen; Suzanne M Gilboa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

2.  Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.

Authors:  Sarah C MacDonald; Jacqueline M Cohen; Alice Panchaud; Thomas F McElrath; Krista F Huybrechts; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-22       Impact factor: 2.890

3.  Validation of mother-infant linkage using Medicaid Case ID variable within the Medicaid Analytic eXtract (MAX) database.

Authors:  Caitlin A Knox; Christian Hampp; Kristin Palmsten; Yanmin Zhu; Soko Setoguchi; Babette Brumback; Richard Segal; Almut G Winterstein
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-07-09       Impact factor: 2.890

4.  Who is pregnant? defining real-world data-based pregnancy episodes in the National COVID Cohort Collaborative (N3C).

Authors:  Sara Jones; Katie R Bradwell; Lauren E Chan; Courtney Olson-Chen; Jessica Tarleton; Kenneth J Wilkins; Qiuyuan Qin; Emily Groene Faherty; Yan Kwan Lau; Catherine Xie; Yu-Han Kao; Michael N Liebman; Federico Mariona; Anup Challa; Li Li; Sarah J Ratcliffe; Julie A McMurry; Melissa A Haendel; Rena C Patel; Elaine L Hill
Journal:  medRxiv       Date:  2022-08-06

5.  Inferring pregnancy episodes and outcomes within a network of observational databases.

Authors:  Amy Matcho; Patrick Ryan; Daniel Fife; Dina Gifkins; Chris Knoll; Andrew Friedman
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

6.  Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial.

Authors:  Babette Bais; Astrid M Kamperman; Hilmar H Bijma; Witte Jg Hoogendijk; Jan L Souman; Esther Knijff; Mijke P Lambregtse-van den Berg
Journal:  BMJ Open       Date:  2020-10-28       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.